CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 4 Open-market sale EVP, R&D AND CSO sold 129,206 shares at an average $7.65 ($988,495)
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale EVP, R&D AND CSO sold 41,783 shares at an average $6.93 ($289,492)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale EVP, R&D AND CSO sold 50,000 shares at $7.13 ($356,500)
- 4 Open-market sale EVP, R&D AND CSO sold 92,377 shares at an average $7.04 ($650,563)
- S-3 Offering Registration Statement
- 4 Open-market sale EVP, R&D AND CSO sold 105,931 shares at an average $6.95 ($736,500)
- 4 Open-market sale EVP, R&D AND CSO sold 12,342 shares at $7.06 ($87,135)
- 4 Open-market sale EVP, R&D AND CSO sold 50,000 shares at $6.76 ($338,000)
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
Page 8 of 17 · 326 filings